中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

药物性胰腺炎的诊断与治疗

钱家鸣 王淑君

引用本文:
Citation:

药物性胰腺炎的诊断与治疗

DOI: 10.3969/j.issn.1001-5256.2014.08.005
详细信息
  • 中图分类号: R576

Diagnosis and treatment of drug- induced pancreatitis

  • 摘要: 药物性胰腺炎(DIP)是药源消化系统疾病之一,随着药物的广泛使用,可引起DIP的药物逐年增加。DIP缺乏特异的临床检测指标及诊治流程,易漏诊。阐述DIP的流行病学、发病机制、引起DIP的药物及分类,强调在诊断过程中收集患者用药史,及时停用可疑药物是诊治的关键,并告知患者引起DIP的相应药物,预防DIP再发。

     

  • [1]VINKLEROVA I, PROCHAZKA M, PROCHAZKA V, et al.Incidence, severity, and etiology of drug-induced acute pancreatitis[J].Dig Dis Sci, 2010, 55 (10) :2977-2981.
    [2]LANKISCH PG, DROGE M, GOTTESLEBEN F.Drug induced acute pancreatitis:incidence and severity[J].Gut, 1995, 37 (4) :565-567.
    [3]ZION MM, GOLDBERG B, SUZMAN MM.Corticotrophin and cortisone in the treatment of scleroderma[J].Q J Med, 1955, 24 (95) :215-227.
    [4]BALANI AR, GRENDELL JH.Drug-induced pancreatitis:incidence, management and prevention[J].Drug Saf, 2008, 31 (10) :823-837.
    [5]ANDERSEN V, SONNE J, ANDERSEN M.Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999[J].Eur J Clin Pharmacol, 2001, 57 (6-7) :517-521.
    [6]MUNK EM, PEDERSEN L, FLOYD A, et al.Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis:a population-based case-control study[J].Am J Gastroenterol, 2004, 99 (5) :884-888.
    [7]NORGAARD M, RATANAJAMIT C, JACOBSEN J, et al.Metronidazole and risk of acute pancreatitis:a population-based case-control study[J].Aliment Pharmacol Ther, 2005, 21 (4) :415-420.
    [8]SCARPELLI DG.Toxicology of the pancreas[J].Toxicol Appl Pharmacol, 1989, 101 (3) :543-554.
    [9]BADALOV N, BARADARIAN R, ISWARA K, et al.Drug-induced acute pancreatitis:an evidence-based review[J].Clin Gastroenterol Hepatol, 2007, 5 (6) :648-661, 644.
    [10]KSIADZYNA D.Drug-induced acute pancreatitis related to medications commonly used in gastroenterology[J].Eur J Intern Med, 2011, 22 (1) :20-25.
    [11]KARCH FE, LASAGNA L.Adverse drug reactions.A critical review[J].JAMA, 1975, 234 (12) :1236-1241.
    [12]TRIVEDI CD, PITCHUMONI CS.Drug-induced pancreatitis:an update[J].J Clin Gastroenterol, 2005, 39 (8) :709-716.
    [13]CAVANAUGH Z, NAUT ER.Acetaminophen-induced pancreatic pseudocyst:first case report[J].Conn Med, 2014, 78 (1) :37-39.
    [14]KIM DB, CHO YK, SONG HJ, et al.A case of acute pancreatitis and acute hepatitis caused by ingestion of Ceramium kondoi[J].Korean J Gastroenterol, 2013, 62 (5) :306-309.
    [15]OKADA T, HONDA S, MIYAGI H, et al.Nafamostat mesilateinduced hepatocellular necrosis in a child with pancreatitis caused by pancreaticobiliary maljunction:drug-induced liver injury[J].Pancreas, 2012, 41 (6) :981-983.
    [16]FARMER AD, BRIND A.Drug-induced liver injury[J].Medicine, 2011, 39 (9) :536-540.
    [17]CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACG clinical guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterology, 2014, 109 (7) :950-966.
    [18]YU Z, JIA JD.Risk factors, diagnostic criteria, and drug discontinuation criteria for drug-induced liver injur[J].J Clin Hepatol, 2013, 29 (9) :674-677. (in Chinese) 禹铮, 贾继东.药物性肝损害的危险因素、诊断规范及停药标准[J].临床肝胆病杂志, 2013, 29 (9) :674-677.
  • 加载中
计量
  • 文章访问数:  3177
  • HTML全文浏览量:  13
  • PDF下载量:  635
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-06-25
  • 出版日期:  2014-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回